Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03101995
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.74 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.74 | |
DR3 | 6-DEOXY-ALPHA-L-GLUCOPYRANOSYL- (1->2)-BETA-D-GULOPYRANOSYL-(1- >3)-2-DEOXY-2-[(1-HYDROXYETHYL)AMINO]- ALPHA-L-TALOPYRANOSE | A | 1ZJ2 | 0.75 | |
DR3 | 6-DEOXY-ALPHA-L-GLUCOPYRANOSYL- (1->2)-BETA-D-GULOPYRANOSYL-(1- >3)-2-DEOXY-2-[(1-HYDROXYETHYL)AMINO]- ALPHA-L-TALOPYRANOSE | A | 1ZI5 | 0.75 | |
CTO | TRIACETYLCHITOTRIOSE | A,B | 1BB5 | 0.75 | |
CTO | TRIACETYLCHITOTRIOSE | B | 2H5Z | 0.75 | |
CTO | TRIACETYLCHITOTRIOSE | A,B,C,D | 2R0H | 0.75 | |
CTO | TRIACETYLCHITOTRIOSE | A,B,C | 2AH9 | 0.75 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.75 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.75 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.78 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1LJN | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1ZU0 | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 2HRH | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 1TW5 | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,H | 2HRG | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | 1 | 2BS7 | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7T | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 2QT6 | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1QBB | 0.76 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7S | 0.76 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | A,D,M,N,Z | 2F4V | 0.76 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | B | 2F4T | 0.76 | |
AH0 | 2-(2-ACETYLAMINO-4-HYDROXY-6,8- DIOXA-BICYCLO[3.2.1]OCT-3-YLOXY)- PROPIONIC ACID | A | 1QTE | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,B,C,D | 2APH | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,P | 1TWQ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A | 1D0K | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | S | 9LYZ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | E,S | 148L | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | D,K | 3CYQ | 0.72 | |
AMU | BETA-N-ACETYLMURAMIC ACID | U | 2AIZ | 0.72 | |
AM2 | APRAMYCIN | B | 2OE8 | 0.81 | |
AM2 | APRAMYCIN | A,B | 2OE5 | 0.81 | |
AM2 | APRAMYCIN | A,B | 1YRJ | 0.81 | |
AM2 | APRAMYCIN | A,B | 2G5K | 0.81 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.77 | |
CNY | 13,15-DIAMINO-2-(AMINOMETHYL)-3,4,9,12- TETRAHYDROXYHEXADECAHYDRO-2H-7,10- EPOXYPYRANO[2,3-B][1,10,4]BENZODIOXAZACYCLODODECIN- 8-YL 2,6-DIAMINO-2,6-DIDEOXYHEXOPYRANOSIDE | A,C,D | 1ZZ5 | 0.76 | |
BGN | N-BUTANOYL-2-AMINO-2-DEOXY-GLUCOPYRANOSIDE | A,B,C,D | 1NWG | 0.73 | |
A16 | 4-O-(4,6-dideoxy-4-{[(1S,2S,3S,4R,5S)- 2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}- alpha-D-glucopyranosyl)-beta-D- glucopyranose | A,B | 2VR5 | 0.75 | |
9CS | (1R,2S,3S,4R,6S)-4,6-DIAMINO-3- [(3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]- 2-HYDROXYCYCLOHEXYL 2,6-DIAMINO- 2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSIDE | A | 2QIR | 0.72 | |
AB6 | (2R)-4-AMINO-N-((1R,2S,3R,4R,5S)- 5-AMINO-4-[(2-AMINO-2-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-2-{2-[(3- AMINOPROPYL)AMINO]ETHOXY}-3-HYDROXYCYCLOHEXYL)- 2-HYDROXYBUTANAMIDE | B | 2F4U | 0.77 | |
ABL | 6-HYDROXYMETHYL-5-(3,4,5-TRIHYDROXY- 6-HYDROXYMETHYL-TETRAHYDRO-PYRAN- 2-YLOXY)-PIPERIDINE-2,3,4-TRIOL | A,B | 1NAA | 0.71 | |
ABL | 6-HYDROXYMETHYL-5-(3,4,5-TRIHYDROXY- 6-HYDROXYMETHYL-TETRAHYDRO-PYRAN- 2-YLOXY)-PIPERIDINE-2,3,4-TRIOL | A | 2AXR | 0.71 | |
AKN | (2R)-4-AMINO-N-{(1R,2S,3S,4R,5S)- 5-AMINO-2-[(3-AMINO-3-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-4-[(6-AMINO- 6-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]- 3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE | A,B | 2G5Q | 0.79 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 3E6J | 0.74 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 1ZJ3 | 0.74 | |
DR2 | 6-DEOXY-ALPHA-L-IDOPYRANOSYL-(1- >2)-ALPHA-D-GLUCOPYRANOSYL-(1->4)- 2-(ACETYLAMINO)-2-DEOXY-BETA-L- GULOPYRANOSE | A | 1ZI4 | 0.74 | |
AS5 | 2-(acetylamino)-4-O-[2-(acetylamino)- 2-deoxy-alpha-L-gulopyranosyl]- 1,5-anhydro-2-deoxy-D-mannitol | A,B | 2VLC | 0.76 |